Compare IQV & KR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | KR |
|---|---|---|
| Founded | 1982 | 1883 |
| Country | United States | United States |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1B | 37.1B |
| IPO Year | 2013 | 2007 |
| Metric | IQV | KR |
|---|---|---|
| Price | $247.64 | $59.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 12 |
| Target Price | ★ $227.13 | $74.25 |
| AVG Volume (30 Days) | 1.3M | ★ 7.2M |
| Earning Date | 05-05-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 2.09% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 1.61 | 1.46 |
| Revenue | $9,739,000,000.00 | ★ $147,642,000,000.00 |
| Revenue This Year | $6.77 | $4.39 |
| Revenue Next Year | $5.89 | $2.30 |
| P/E Ratio | $151.84 | ★ $40.49 |
| Revenue Growth | ★ 41.60 | 0.35 |
| 52 Week Low | $154.50 | $54.15 |
| 52 Week High | $247.72 | $76.58 |
| Indicator | IQV | KR |
|---|---|---|
| Relative Strength Index (RSI) | 80.75 | 54.98 |
| Support Level | $159.91 | $55.33 |
| Resistance Level | N/A | $61.28 |
| Average True Range (ATR) | 6.70 | 1.53 |
| MACD | 3.10 | 0.36 |
| Stochastic Oscillator | 92.37 | 84.34 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Founded in 1883, Kroger is the largest pure-play supermarket operator in the United States, operating roughly 2,700 stores across more than 30 banners. Kroger's business is primarily grocery-led (roughly 78% of sales), spanning fresh food and private-label offerings, complemented by fuel centers (9%) and pharmacies (12%). The firm also generates income from advertising, data analytics, and manufacturing.